nodes	percent_of_prediction	percent_of_DWPC	metapath
Toremifene—ESR1—hematologic cancer	0.203	0.702	CbGaD
Toremifene—ABCB1—hematologic cancer	0.0861	0.298	CbGaD
Toremifene—CYP1A2—Anagrelide—hematologic cancer	0.0249	0.054	CbGbCtD
Toremifene—CYP1A1—Methoxsalen—hematologic cancer	0.0249	0.0539	CbGbCtD
Toremifene—CYP1A1—Bortezomib—hematologic cancer	0.0237	0.0513	CbGbCtD
Toremifene—CYP1A1—Daunorubicin—hematologic cancer	0.0227	0.0491	CbGbCtD
Toremifene—CYP1A1—Thalidomide—hematologic cancer	0.0206	0.0447	CbGbCtD
Toremifene—CYP1A1—Dacarbazine—hematologic cancer	0.0177	0.0384	CbGbCtD
Toremifene—ABCB1—Lenalidomide—hematologic cancer	0.0151	0.0327	CbGbCtD
Toremifene—CYP1A1—Dasatinib—hematologic cancer	0.0139	0.0302	CbGbCtD
Toremifene—CYP1A2—Carmustine—hematologic cancer	0.0131	0.0283	CbGbCtD
Toremifene—CYP1A2—Methoxsalen—hematologic cancer	0.0111	0.0241	CbGbCtD
Toremifene—CYP1A2—Bortezomib—hematologic cancer	0.0106	0.0229	CbGbCtD
Toremifene—CYP1A2—Daunorubicin—hematologic cancer	0.0101	0.0219	CbGbCtD
Toremifene—CYP1A2—Alitretinoin—hematologic cancer	0.00992	0.0215	CbGbCtD
Toremifene—CYP1A2—Thalidomide—hematologic cancer	0.00922	0.02	CbGbCtD
Toremifene—CYP3A4—Bexarotene—hematologic cancer	0.00905	0.0196	CbGbCtD
Toremifene—ABCB1—Daunorubicin—hematologic cancer	0.00885	0.0192	CbGbCtD
Toremifene—ABCB1—Alitretinoin—hematologic cancer	0.00867	0.0188	CbGbCtD
Toremifene—CYP3A4—Busulfan—hematologic cancer	0.00841	0.0182	CbGbCtD
Toremifene—CYP3A4—Lomustine—hematologic cancer	0.00841	0.0182	CbGbCtD
Toremifene—CYP1A2—Dacarbazine—hematologic cancer	0.00793	0.0172	CbGbCtD
Toremifene—CYP1A2—Imatinib—hematologic cancer	0.00775	0.0168	CbGbCtD
Toremifene—ESR1—ovarian follicle—hematologic cancer	0.00764	0.443	CbGeAlD
Toremifene—CYP3A4—Thiotepa—hematologic cancer	0.00749	0.0162	CbGbCtD
Toremifene—CYP1A1—Dexamethasone—hematologic cancer	0.00714	0.0155	CbGbCtD
Toremifene—ABCB1—Imatinib—hematologic cancer	0.00678	0.0147	CbGbCtD
Toremifene—CYP1A2—Dasatinib—hematologic cancer	0.00623	0.0135	CbGbCtD
Toremifene—ABCB1—Nilotinib—hematologic cancer	0.00616	0.0133	CbGbCtD
Toremifene—ABCB1—Vinorelbine—hematologic cancer	0.00611	0.0132	CbGbCtD
Toremifene—CYP3A4—Methoxsalen—hematologic cancer	0.00583	0.0126	CbGbCtD
Toremifene—CYP3A4—Bortezomib—hematologic cancer	0.00554	0.012	CbGbCtD
Toremifene—ABCB1—Dasatinib—hematologic cancer	0.00544	0.0118	CbGbCtD
Toremifene—ABCB1—Mitoxantrone—hematologic cancer	0.00538	0.0117	CbGbCtD
Toremifene—CYP3A4—Daunorubicin—hematologic cancer	0.0053	0.0115	CbGbCtD
Toremifene—ABCB1—Betamethasone—hematologic cancer	0.00479	0.0104	CbGbCtD
Toremifene—ABCB1—Gemcitabine—hematologic cancer	0.00475	0.0103	CbGbCtD
Toremifene—ABCB1—Prednisolone—hematologic cancer	0.00473	0.0102	CbGbCtD
Toremifene—CYP3A4—Cytarabine—hematologic cancer	0.00468	0.0101	CbGbCtD
Toremifene—CYP3A4—Teniposide—hematologic cancer	0.00461	0.00998	CbGbCtD
Toremifene—ABCB1—Prednisone—hematologic cancer	0.00447	0.00968	CbGbCtD
Toremifene—CYP3A4—Ifosfamide—hematologic cancer	0.00425	0.00921	CbGbCtD
Toremifene—ABCB1—Irinotecan—hematologic cancer	0.00423	0.00917	CbGbCtD
Toremifene—CYP3A4—Imatinib—hematologic cancer	0.00406	0.0088	CbGbCtD
Toremifene—CYP1A2—Etoposide—hematologic cancer	0.00388	0.0084	CbGbCtD
Toremifene—CYP3A4—Ruxolitinib—hematologic cancer	0.00382	0.00829	CbGbCtD
Toremifene—ABCB1—Vinblastine—hematologic cancer	0.00376	0.00816	CbGbCtD
Toremifene—ABCB1—Vincristine—hematologic cancer	0.0037	0.00802	CbGbCtD
Toremifene—CYP3A4—Nilotinib—hematologic cancer	0.00369	0.008	CbGbCtD
Toremifene—CYP3A4—Vinorelbine—hematologic cancer	0.00366	0.00793	CbGbCtD
Toremifene—ABCB1—Cisplatin—hematologic cancer	0.00345	0.00748	CbGbCtD
Toremifene—ABCB1—Etoposide—hematologic cancer	0.00339	0.00735	CbGbCtD
Toremifene—CYP3A4—Triamcinolone—hematologic cancer	0.00335	0.00725	CbGbCtD
Toremifene—CYP3A4—Dasatinib—hematologic cancer	0.00326	0.00707	CbGbCtD
Toremifene—CYP3A4—Mitoxantrone—hematologic cancer	0.00322	0.00698	CbGbCtD
Toremifene—CYP3A4—Betamethasone—hematologic cancer	0.00287	0.00622	CbGbCtD
Toremifene—CYP3A4—Prednisolone—hematologic cancer	0.00283	0.00614	CbGbCtD
Toremifene—ABCB1—Dexamethasone—hematologic cancer	0.00279	0.00604	CbGbCtD
Toremifene—CYP3A4—Prednisone—hematologic cancer	0.00268	0.0058	CbGbCtD
Toremifene—CYP3A4—Irinotecan—hematologic cancer	0.00254	0.0055	CbGbCtD
Toremifene—ABCB1—Doxorubicin—hematologic cancer	0.00231	0.00501	CbGbCtD
Toremifene—CYP3A4—Vinblastine—hematologic cancer	0.00226	0.00489	CbGbCtD
Toremifene—ABCB1—Methotrexate—hematologic cancer	0.00224	0.00485	CbGbCtD
Toremifene—CYP3A4—Vincristine—hematologic cancer	0.00222	0.0048	CbGbCtD
Toremifene—CYP3A4—Etoposide—hematologic cancer	0.00203	0.0044	CbGbCtD
Toremifene—CYP3A4—Dexamethasone—hematologic cancer	0.00167	0.00362	CbGbCtD
Toremifene—CYP3A4—Doxorubicin—hematologic cancer	0.00139	0.003	CbGbCtD
Toremifene—ESR1—hematopoietic system—hematologic cancer	0.000923	0.0534	CbGeAlD
Toremifene—CYP1A2—hematopoietic system—hematologic cancer	0.000711	0.0412	CbGeAlD
Toremifene—CYP1A1—hematopoietic system—hematologic cancer	0.000702	0.0406	CbGeAlD
Toremifene—ESR1—gonad—hematologic cancer	0.000701	0.0406	CbGeAlD
Toremifene—ESR1—blood—hematologic cancer	0.000611	0.0354	CbGeAlD
Toremifene—ESR1—lung—hematologic cancer	0.000536	0.031	CbGeAlD
Toremifene—CYP3A4—hematopoietic system—hematologic cancer	0.000515	0.0298	CbGeAlD
Toremifene—ESR1—testis—hematologic cancer	0.000506	0.0293	CbGeAlD
Toremifene—CYP1A2—blood—hematologic cancer	0.000471	0.0273	CbGeAlD
Toremifene—CYP1A1—blood—hematologic cancer	0.000465	0.0269	CbGeAlD
Toremifene—CYP1A2—lung—hematologic cancer	0.000413	0.0239	CbGeAlD
Toremifene—CYP1A1—lung—hematologic cancer	0.000407	0.0236	CbGeAlD
Toremifene—ESR1—lymph node—hematologic cancer	0.000366	0.0212	CbGeAlD
Toremifene—ABCB1—hematopoietic system—hematologic cancer	0.000364	0.0211	CbGeAlD
Toremifene—CYP3A4—blood—hematologic cancer	0.000341	0.0198	CbGeAlD
Toremifene—CYP1A1—lymph node—hematologic cancer	0.000279	0.0161	CbGeAlD
Toremifene—ABCB1—gonad—hematologic cancer	0.000277	0.016	CbGeAlD
Toremifene—Ospemifene—ESR1—hematologic cancer	0.000247	0.246	CrCbGaD
Toremifene—ABCB1—blood—hematologic cancer	0.000241	0.014	CbGeAlD
Toremifene—ABCB1—bone marrow—hematologic cancer	0.000234	0.0135	CbGeAlD
Toremifene—ABCB1—lung—hematologic cancer	0.000212	0.0123	CbGeAlD
Toremifene—ABCB1—testis—hematologic cancer	0.0002	0.0116	CbGeAlD
Toremifene—Clomifene—ESR1—hematologic cancer	0.000174	0.173	CrCbGaD
Toremifene—ABCB1—lymph node—hematologic cancer	0.000145	0.00838	CbGeAlD
Toremifene—Phenoxybenzamine—SLC22A1—hematologic cancer	0.000144	0.143	CrCbGaD
Toremifene—Diphenhydramine—SLC22A1—hematologic cancer	0.00012	0.12	CrCbGaD
Toremifene—Tamoxifen—ABCG2—hematologic cancer	8.2e-05	0.0818	CrCbGaD
Toremifene—Tamoxifen—ESR1—hematologic cancer	8.03e-05	0.0801	CrCbGaD
Toremifene—Clomifene—ABCB1—hematologic cancer	7.38e-05	0.0737	CrCbGaD
Toremifene—Loperamide—ABCB1—hematologic cancer	4.75e-05	0.0474	CrCbGaD
Toremifene—Neuropathy peripheral—Epirubicin—hematologic cancer	3.46e-05	0.000205	CcSEcCtD
Toremifene—Jaundice—Epirubicin—hematologic cancer	3.44e-05	0.000204	CcSEcCtD
Toremifene—Vomiting—Thalidomide—hematologic cancer	3.44e-05	0.000203	CcSEcCtD
Toremifene—Dizziness—Carmustine—hematologic cancer	3.43e-05	0.000203	CcSEcCtD
Toremifene—Constipation—Etoposide—hematologic cancer	3.43e-05	0.000203	CcSEcCtD
Toremifene—Pain—Etoposide—hematologic cancer	3.43e-05	0.000203	CcSEcCtD
Toremifene—Tamoxifen—ABCB1—hematologic cancer	3.41e-05	0.034	CrCbGaD
Toremifene—Rash—Thalidomide—hematologic cancer	3.41e-05	0.000202	CcSEcCtD
Toremifene—Dermatitis—Thalidomide—hematologic cancer	3.4e-05	0.000202	CcSEcCtD
Toremifene—Dizziness—Alitretinoin—hematologic cancer	3.4e-05	0.000201	CcSEcCtD
Toremifene—Headache—Thalidomide—hematologic cancer	3.39e-05	0.0002	CcSEcCtD
Toremifene—Pain—Prednisolone—hematologic cancer	3.39e-05	0.0002	CcSEcCtD
Toremifene—Sweating—Epirubicin—hematologic cancer	3.38e-05	0.0002	CcSEcCtD
Toremifene—Asthenia—Gemcitabine—hematologic cancer	3.37e-05	0.0002	CcSEcCtD
Toremifene—Dizziness—Ifosfamide—hematologic cancer	3.36e-05	0.000199	CcSEcCtD
Toremifene—Hepatobiliary disease—Epirubicin—hematologic cancer	3.34e-05	0.000198	CcSEcCtD
Toremifene—Weight increased—Doxorubicin—hematologic cancer	3.33e-05	0.000197	CcSEcCtD
Toremifene—Pruritus—Gemcitabine—hematologic cancer	3.33e-05	0.000197	CcSEcCtD
Toremifene—Vision blurred—Prednisone—hematologic cancer	3.32e-05	0.000197	CcSEcCtD
Toremifene—Nausea—Thiotepa—hematologic cancer	3.32e-05	0.000197	CcSEcCtD
Toremifene—Oedema—Betamethasone—hematologic cancer	3.3e-05	0.000196	CcSEcCtD
Toremifene—Oedema—Dexamethasone—hematologic cancer	3.3e-05	0.000196	CcSEcCtD
Toremifene—Vomiting—Carmustine—hematologic cancer	3.3e-05	0.000195	CcSEcCtD
Toremifene—Insomnia—Triamcinolone—hematologic cancer	3.29e-05	0.000195	CcSEcCtD
Toremifene—Dizziness—Vincristine—hematologic cancer	3.28e-05	0.000194	CcSEcCtD
Toremifene—Rash—Carmustine—hematologic cancer	3.27e-05	0.000194	CcSEcCtD
Toremifene—Dermatitis—Carmustine—hematologic cancer	3.27e-05	0.000194	CcSEcCtD
Toremifene—Vomiting—Alitretinoin—hematologic cancer	3.27e-05	0.000194	CcSEcCtD
Toremifene—Visual impairment—Methotrexate—hematologic cancer	3.26e-05	0.000193	CcSEcCtD
Toremifene—Headache—Carmustine—hematologic cancer	3.25e-05	0.000193	CcSEcCtD
Toremifene—Dyspnoea—Triamcinolone—hematologic cancer	3.25e-05	0.000192	CcSEcCtD
Toremifene—Rash—Alitretinoin—hematologic cancer	3.24e-05	0.000192	CcSEcCtD
Toremifene—Nervous system disorder—Betamethasone—hematologic cancer	3.24e-05	0.000192	CcSEcCtD
Toremifene—Nervous system disorder—Dexamethasone—hematologic cancer	3.24e-05	0.000192	CcSEcCtD
Toremifene—Dermatitis—Alitretinoin—hematologic cancer	3.24e-05	0.000192	CcSEcCtD
Toremifene—Thrombocytopenia—Dexamethasone—hematologic cancer	3.23e-05	0.000191	CcSEcCtD
Toremifene—Thrombocytopenia—Betamethasone—hematologic cancer	3.23e-05	0.000191	CcSEcCtD
Toremifene—Vomiting—Ifosfamide—hematologic cancer	3.23e-05	0.000191	CcSEcCtD
Toremifene—Headache—Alitretinoin—hematologic cancer	3.22e-05	0.000191	CcSEcCtD
Toremifene—Nausea—Thalidomide—hematologic cancer	3.21e-05	0.00019	CcSEcCtD
Toremifene—Rash—Ifosfamide—hematologic cancer	3.2e-05	0.00019	CcSEcCtD
Toremifene—Dermatitis—Ifosfamide—hematologic cancer	3.2e-05	0.00019	CcSEcCtD
Toremifene—Neuropathy peripheral—Doxorubicin—hematologic cancer	3.2e-05	0.000189	CcSEcCtD
Toremifene—Hyperhidrosis—Betamethasone—hematologic cancer	3.19e-05	0.000189	CcSEcCtD
Toremifene—Hyperhidrosis—Dexamethasone—hematologic cancer	3.19e-05	0.000189	CcSEcCtD
Toremifene—Dizziness—Irinotecan—hematologic cancer	3.19e-05	0.000189	CcSEcCtD
Toremifene—Jaundice—Doxorubicin—hematologic cancer	3.18e-05	0.000188	CcSEcCtD
Toremifene—Vertigo—Prednisone—hematologic cancer	3.17e-05	0.000188	CcSEcCtD
Toremifene—Eye disorder—Methotrexate—hematologic cancer	3.16e-05	0.000187	CcSEcCtD
Toremifene—Vomiting—Vincristine—hematologic cancer	3.15e-05	0.000187	CcSEcCtD
Toremifene—Anorexia—Betamethasone—hematologic cancer	3.15e-05	0.000186	CcSEcCtD
Toremifene—Anorexia—Dexamethasone—hematologic cancer	3.15e-05	0.000186	CcSEcCtD
Toremifene—Asthenia—Cisplatin—hematologic cancer	3.14e-05	0.000186	CcSEcCtD
Toremifene—Fatigue—Triamcinolone—hematologic cancer	3.14e-05	0.000186	CcSEcCtD
Toremifene—Sweating—Doxorubicin—hematologic cancer	3.13e-05	0.000185	CcSEcCtD
Toremifene—Rash—Vincristine—hematologic cancer	3.12e-05	0.000185	CcSEcCtD
Toremifene—Dermatitis—Vincristine—hematologic cancer	3.12e-05	0.000185	CcSEcCtD
Toremifene—Pain—Triamcinolone—hematologic cancer	3.11e-05	0.000184	CcSEcCtD
Toremifene—Headache—Vincristine—hematologic cancer	3.1e-05	0.000184	CcSEcCtD
Toremifene—Hepatobiliary disease—Doxorubicin—hematologic cancer	3.09e-05	0.000183	CcSEcCtD
Toremifene—Nausea—Carmustine—hematologic cancer	3.08e-05	0.000183	CcSEcCtD
Toremifene—Angiopathy—Methotrexate—hematologic cancer	3.07e-05	0.000182	CcSEcCtD
Toremifene—Vomiting—Irinotecan—hematologic cancer	3.07e-05	0.000182	CcSEcCtD
Toremifene—Vomiting—Mitoxantrone—hematologic cancer	3.07e-05	0.000182	CcSEcCtD
Toremifene—Nausea—Alitretinoin—hematologic cancer	3.05e-05	0.000181	CcSEcCtD
Toremifene—Visual impairment—Epirubicin—hematologic cancer	3.05e-05	0.000181	CcSEcCtD
Toremifene—Mediastinal disorder—Methotrexate—hematologic cancer	3.05e-05	0.000181	CcSEcCtD
Toremifene—Rash—Mitoxantrone—hematologic cancer	3.04e-05	0.00018	CcSEcCtD
Toremifene—Rash—Irinotecan—hematologic cancer	3.04e-05	0.00018	CcSEcCtD
Toremifene—Dermatitis—Mitoxantrone—hematologic cancer	3.04e-05	0.00018	CcSEcCtD
Toremifene—Dermatitis—Irinotecan—hematologic cancer	3.04e-05	0.00018	CcSEcCtD
Toremifene—Chills—Methotrexate—hematologic cancer	3.04e-05	0.00018	CcSEcCtD
Toremifene—Headache—Irinotecan—hematologic cancer	3.02e-05	0.000179	CcSEcCtD
Toremifene—Headache—Mitoxantrone—hematologic cancer	3.02e-05	0.000179	CcSEcCtD
Toremifene—Nausea—Ifosfamide—hematologic cancer	3.02e-05	0.000179	CcSEcCtD
Toremifene—Alopecia—Methotrexate—hematologic cancer	2.99e-05	0.000177	CcSEcCtD
Toremifene—Vomiting—Gemcitabine—hematologic cancer	2.99e-05	0.000177	CcSEcCtD
Toremifene—Insomnia—Dexamethasone—hematologic cancer	2.99e-05	0.000177	CcSEcCtD
Toremifene—Insomnia—Betamethasone—hematologic cancer	2.99e-05	0.000177	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	2.98e-05	0.000176	CcSEcCtD
Toremifene—Mental disorder—Methotrexate—hematologic cancer	2.96e-05	0.000176	CcSEcCtD
Toremifene—Rash—Gemcitabine—hematologic cancer	2.96e-05	0.000175	CcSEcCtD
Toremifene—Dermatitis—Gemcitabine—hematologic cancer	2.96e-05	0.000175	CcSEcCtD
Toremifene—Eye disorder—Epirubicin—hematologic cancer	2.96e-05	0.000175	CcSEcCtD
Toremifene—Malnutrition—Methotrexate—hematologic cancer	2.95e-05	0.000174	CcSEcCtD
Toremifene—Headache—Gemcitabine—hematologic cancer	2.94e-05	0.000174	CcSEcCtD
Toremifene—Nausea—Vincristine—hematologic cancer	2.94e-05	0.000174	CcSEcCtD
Toremifene—Asthenia—Etoposide—hematologic cancer	2.88e-05	0.000171	CcSEcCtD
Toremifene—Oedema—Prednisone—hematologic cancer	2.88e-05	0.00017	CcSEcCtD
Toremifene—Angiopathy—Epirubicin—hematologic cancer	2.87e-05	0.00017	CcSEcCtD
Toremifene—Decreased appetite—Betamethasone—hematologic cancer	2.87e-05	0.00017	CcSEcCtD
Toremifene—Decreased appetite—Dexamethasone—hematologic cancer	2.87e-05	0.00017	CcSEcCtD
Toremifene—Nausea—Irinotecan—hematologic cancer	2.87e-05	0.00017	CcSEcCtD
Toremifene—Nausea—Mitoxantrone—hematologic cancer	2.87e-05	0.00017	CcSEcCtD
Toremifene—Mediastinal disorder—Epirubicin—hematologic cancer	2.85e-05	0.000169	CcSEcCtD
Toremifene—Gastrointestinal disorder—Dexamethasone—hematologic cancer	2.85e-05	0.000169	CcSEcCtD
Toremifene—Gastrointestinal disorder—Betamethasone—hematologic cancer	2.85e-05	0.000169	CcSEcCtD
Toremifene—Back pain—Methotrexate—hematologic cancer	2.85e-05	0.000169	CcSEcCtD
Toremifene—Fatigue—Betamethasone—hematologic cancer	2.85e-05	0.000169	CcSEcCtD
Toremifene—Fatigue—Dexamethasone—hematologic cancer	2.85e-05	0.000169	CcSEcCtD
Toremifene—Chills—Epirubicin—hematologic cancer	2.84e-05	0.000168	CcSEcCtD
Toremifene—Pruritus—Etoposide—hematologic cancer	2.84e-05	0.000168	CcSEcCtD
Toremifene—Arrhythmia—Epirubicin—hematologic cancer	2.83e-05	0.000167	CcSEcCtD
Toremifene—Pain—Betamethasone—hematologic cancer	2.83e-05	0.000167	CcSEcCtD
Toremifene—Pain—Dexamethasone—hematologic cancer	2.83e-05	0.000167	CcSEcCtD
Toremifene—Visual impairment—Doxorubicin—hematologic cancer	2.82e-05	0.000167	CcSEcCtD
Toremifene—Nervous system disorder—Prednisone—hematologic cancer	2.82e-05	0.000167	CcSEcCtD
Toremifene—Alopecia—Epirubicin—hematologic cancer	2.8e-05	0.000166	CcSEcCtD
Toremifene—Skin disorder—Prednisone—hematologic cancer	2.79e-05	0.000165	CcSEcCtD
Toremifene—Nausea—Gemcitabine—hematologic cancer	2.79e-05	0.000165	CcSEcCtD
Toremifene—Vomiting—Cisplatin—hematologic cancer	2.79e-05	0.000165	CcSEcCtD
Toremifene—Hyperhidrosis—Prednisone—hematologic cancer	2.78e-05	0.000165	CcSEcCtD
Toremifene—Vision blurred—Methotrexate—hematologic cancer	2.78e-05	0.000164	CcSEcCtD
Toremifene—Mental disorder—Epirubicin—hematologic cancer	2.77e-05	0.000164	CcSEcCtD
Toremifene—Rash—Cisplatin—hematologic cancer	2.76e-05	0.000164	CcSEcCtD
Toremifene—Dermatitis—Cisplatin—hematologic cancer	2.76e-05	0.000163	CcSEcCtD
Toremifene—Malnutrition—Epirubicin—hematologic cancer	2.76e-05	0.000163	CcSEcCtD
Toremifene—Anorexia—Prednisone—hematologic cancer	2.74e-05	0.000162	CcSEcCtD
Toremifene—Eye disorder—Doxorubicin—hematologic cancer	2.74e-05	0.000162	CcSEcCtD
Toremifene—Back pain—Epirubicin—hematologic cancer	2.67e-05	0.000158	CcSEcCtD
Toremifene—Angiopathy—Doxorubicin—hematologic cancer	2.66e-05	0.000157	CcSEcCtD
Toremifene—Dizziness—Etoposide—hematologic cancer	2.65e-05	0.000157	CcSEcCtD
Toremifene—Vertigo—Methotrexate—hematologic cancer	2.65e-05	0.000157	CcSEcCtD
Toremifene—Mediastinal disorder—Doxorubicin—hematologic cancer	2.64e-05	0.000156	CcSEcCtD
Toremifene—Leukopenia—Methotrexate—hematologic cancer	2.64e-05	0.000156	CcSEcCtD
Toremifene—Chills—Doxorubicin—hematologic cancer	2.63e-05	0.000156	CcSEcCtD
Toremifene—Dizziness—Prednisolone—hematologic cancer	2.62e-05	0.000155	CcSEcCtD
Toremifene—Arrhythmia—Doxorubicin—hematologic cancer	2.62e-05	0.000155	CcSEcCtD
Toremifene—Asthenia—Triamcinolone—hematologic cancer	2.61e-05	0.000155	CcSEcCtD
Toremifene—Nausea—Cisplatin—hematologic cancer	2.6e-05	0.000154	CcSEcCtD
Toremifene—Insomnia—Prednisone—hematologic cancer	2.6e-05	0.000154	CcSEcCtD
Toremifene—Vision blurred—Epirubicin—hematologic cancer	2.6e-05	0.000154	CcSEcCtD
Toremifene—Alopecia—Doxorubicin—hematologic cancer	2.59e-05	0.000153	CcSEcCtD
Toremifene—Pruritus—Triamcinolone—hematologic cancer	2.58e-05	0.000152	CcSEcCtD
Toremifene—Mental disorder—Doxorubicin—hematologic cancer	2.57e-05	0.000152	CcSEcCtD
Toremifene—Vomiting—Etoposide—hematologic cancer	2.55e-05	0.000151	CcSEcCtD
Toremifene—Malnutrition—Doxorubicin—hematologic cancer	2.55e-05	0.000151	CcSEcCtD
Toremifene—Rash—Etoposide—hematologic cancer	2.53e-05	0.00015	CcSEcCtD
Toremifene—Dermatitis—Etoposide—hematologic cancer	2.53e-05	0.00015	CcSEcCtD
Toremifene—Headache—Etoposide—hematologic cancer	2.51e-05	0.000149	CcSEcCtD
Toremifene—Chest pain—Methotrexate—hematologic cancer	2.51e-05	0.000148	CcSEcCtD
Toremifene—Decreased appetite—Prednisone—hematologic cancer	2.5e-05	0.000148	CcSEcCtD
Toremifene—Rash—Prednisolone—hematologic cancer	2.5e-05	0.000148	CcSEcCtD
Toremifene—Dermatitis—Prednisolone—hematologic cancer	2.49e-05	0.000148	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	2.49e-05	0.000147	CcSEcCtD
Toremifene—Fatigue—Prednisone—hematologic cancer	2.48e-05	0.000147	CcSEcCtD
Toremifene—Headache—Prednisolone—hematologic cancer	2.48e-05	0.000147	CcSEcCtD
Toremifene—Vertigo—Epirubicin—hematologic cancer	2.48e-05	0.000147	CcSEcCtD
Toremifene—Leukopenia—Epirubicin—hematologic cancer	2.47e-05	0.000146	CcSEcCtD
Toremifene—Back pain—Doxorubicin—hematologic cancer	2.47e-05	0.000146	CcSEcCtD
Toremifene—Constipation—Prednisone—hematologic cancer	2.46e-05	0.000146	CcSEcCtD
Toremifene—Dizziness—Triamcinolone—hematologic cancer	2.41e-05	0.000143	CcSEcCtD
Toremifene—Vision blurred—Doxorubicin—hematologic cancer	2.4e-05	0.000142	CcSEcCtD
Toremifene—Nausea—Etoposide—hematologic cancer	2.38e-05	0.000141	CcSEcCtD
Toremifene—Asthenia—Dexamethasone—hematologic cancer	2.37e-05	0.00014	CcSEcCtD
Toremifene—Asthenia—Betamethasone—hematologic cancer	2.37e-05	0.00014	CcSEcCtD
Toremifene—Nervous system disorder—Methotrexate—hematologic cancer	2.36e-05	0.00014	CcSEcCtD
Toremifene—Thrombocytopenia—Methotrexate—hematologic cancer	2.35e-05	0.000139	CcSEcCtD
Toremifene—Nausea—Prednisolone—hematologic cancer	2.35e-05	0.000139	CcSEcCtD
Toremifene—Chest pain—Epirubicin—hematologic cancer	2.35e-05	0.000139	CcSEcCtD
Toremifene—Pruritus—Dexamethasone—hematologic cancer	2.34e-05	0.000138	CcSEcCtD
Toremifene—Pruritus—Betamethasone—hematologic cancer	2.34e-05	0.000138	CcSEcCtD
Toremifene—Skin disorder—Methotrexate—hematologic cancer	2.34e-05	0.000138	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	2.33e-05	0.000138	CcSEcCtD
Toremifene—Hyperhidrosis—Methotrexate—hematologic cancer	2.32e-05	0.000138	CcSEcCtD
Toremifene—Vomiting—Triamcinolone—hematologic cancer	2.31e-05	0.000137	CcSEcCtD
Toremifene—Rash—Triamcinolone—hematologic cancer	2.3e-05	0.000136	CcSEcCtD
Toremifene—Dermatitis—Triamcinolone—hematologic cancer	2.29e-05	0.000136	CcSEcCtD
Toremifene—Vertigo—Doxorubicin—hematologic cancer	2.29e-05	0.000136	CcSEcCtD
Toremifene—Anorexia—Methotrexate—hematologic cancer	2.29e-05	0.000136	CcSEcCtD
Toremifene—Leukopenia—Doxorubicin—hematologic cancer	2.28e-05	0.000135	CcSEcCtD
Toremifene—Headache—Triamcinolone—hematologic cancer	2.28e-05	0.000135	CcSEcCtD
Toremifene—Oedema—Epirubicin—hematologic cancer	2.25e-05	0.000133	CcSEcCtD
Toremifene—Nervous system disorder—Epirubicin—hematologic cancer	2.21e-05	0.000131	CcSEcCtD
Toremifene—Thrombocytopenia—Epirubicin—hematologic cancer	2.2e-05	0.00013	CcSEcCtD
Toremifene—Skin disorder—Epirubicin—hematologic cancer	2.19e-05	0.000129	CcSEcCtD
Toremifene—Dizziness—Betamethasone—hematologic cancer	2.18e-05	0.000129	CcSEcCtD
Toremifene—Dizziness—Dexamethasone—hematologic cancer	2.18e-05	0.000129	CcSEcCtD
Toremifene—Hyperhidrosis—Epirubicin—hematologic cancer	2.18e-05	0.000129	CcSEcCtD
Toremifene—Insomnia—Methotrexate—hematologic cancer	2.17e-05	0.000129	CcSEcCtD
Toremifene—Chest pain—Doxorubicin—hematologic cancer	2.17e-05	0.000129	CcSEcCtD
Toremifene—Nausea—Triamcinolone—hematologic cancer	2.16e-05	0.000128	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.16e-05	0.000128	CcSEcCtD
Toremifene—Anorexia—Epirubicin—hematologic cancer	2.14e-05	0.000127	CcSEcCtD
Toremifene—Dyspnoea—Methotrexate—hematologic cancer	2.14e-05	0.000127	CcSEcCtD
Toremifene—Vomiting—Dexamethasone—hematologic cancer	2.1e-05	0.000124	CcSEcCtD
Toremifene—Vomiting—Betamethasone—hematologic cancer	2.1e-05	0.000124	CcSEcCtD
Toremifene—Decreased appetite—Methotrexate—hematologic cancer	2.09e-05	0.000124	CcSEcCtD
Toremifene—Rash—Betamethasone—hematologic cancer	2.08e-05	0.000123	CcSEcCtD
Toremifene—Rash—Dexamethasone—hematologic cancer	2.08e-05	0.000123	CcSEcCtD
Toremifene—Oedema—Doxorubicin—hematologic cancer	2.08e-05	0.000123	CcSEcCtD
Toremifene—Dermatitis—Betamethasone—hematologic cancer	2.08e-05	0.000123	CcSEcCtD
Toremifene—Dermatitis—Dexamethasone—hematologic cancer	2.08e-05	0.000123	CcSEcCtD
Toremifene—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.08e-05	0.000123	CcSEcCtD
Toremifene—Fatigue—Methotrexate—hematologic cancer	2.07e-05	0.000123	CcSEcCtD
Toremifene—Headache—Dexamethasone—hematologic cancer	2.07e-05	0.000123	CcSEcCtD
Toremifene—Headache—Betamethasone—hematologic cancer	2.07e-05	0.000123	CcSEcCtD
Toremifene—Asthenia—Prednisone—hematologic cancer	2.06e-05	0.000122	CcSEcCtD
Toremifene—Pain—Methotrexate—hematologic cancer	2.06e-05	0.000122	CcSEcCtD
Toremifene—Nervous system disorder—Doxorubicin—hematologic cancer	2.04e-05	0.000121	CcSEcCtD
Toremifene—Thrombocytopenia—Doxorubicin—hematologic cancer	2.04e-05	0.000121	CcSEcCtD
Toremifene—Pruritus—Prednisone—hematologic cancer	2.04e-05	0.000121	CcSEcCtD
Toremifene—Insomnia—Epirubicin—hematologic cancer	2.04e-05	0.00012	CcSEcCtD
Toremifene—Skin disorder—Doxorubicin—hematologic cancer	2.02e-05	0.00012	CcSEcCtD
Toremifene—Hyperhidrosis—Doxorubicin—hematologic cancer	2.01e-05	0.000119	CcSEcCtD
Toremifene—Dyspnoea—Epirubicin—hematologic cancer	2.01e-05	0.000119	CcSEcCtD
Toremifene—Anorexia—Doxorubicin—hematologic cancer	1.98e-05	0.000117	CcSEcCtD
Toremifene—Nausea—Dexamethasone—hematologic cancer	1.96e-05	0.000116	CcSEcCtD
Toremifene—Nausea—Betamethasone—hematologic cancer	1.96e-05	0.000116	CcSEcCtD
Toremifene—Decreased appetite—Epirubicin—hematologic cancer	1.96e-05	0.000116	CcSEcCtD
Toremifene—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.94e-05	0.000115	CcSEcCtD
Toremifene—Fatigue—Epirubicin—hematologic cancer	1.94e-05	0.000115	CcSEcCtD
Toremifene—Constipation—Epirubicin—hematologic cancer	1.92e-05	0.000114	CcSEcCtD
Toremifene—Pain—Epirubicin—hematologic cancer	1.92e-05	0.000114	CcSEcCtD
Toremifene—Dizziness—Prednisone—hematologic cancer	1.9e-05	0.000113	CcSEcCtD
Toremifene—Insomnia—Doxorubicin—hematologic cancer	1.88e-05	0.000111	CcSEcCtD
Toremifene—Dyspnoea—Doxorubicin—hematologic cancer	1.86e-05	0.00011	CcSEcCtD
Toremifene—Vomiting—Prednisone—hematologic cancer	1.83e-05	0.000108	CcSEcCtD
Toremifene—Rash—Prednisone—hematologic cancer	1.81e-05	0.000107	CcSEcCtD
Toremifene—Dermatitis—Prednisone—hematologic cancer	1.81e-05	0.000107	CcSEcCtD
Toremifene—Decreased appetite—Doxorubicin—hematologic cancer	1.81e-05	0.000107	CcSEcCtD
Toremifene—Headache—Prednisone—hematologic cancer	1.8e-05	0.000107	CcSEcCtD
Toremifene—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.8e-05	0.000106	CcSEcCtD
Toremifene—Fatigue—Doxorubicin—hematologic cancer	1.79e-05	0.000106	CcSEcCtD
Toremifene—Pain—Doxorubicin—hematologic cancer	1.78e-05	0.000105	CcSEcCtD
Toremifene—Constipation—Doxorubicin—hematologic cancer	1.78e-05	0.000105	CcSEcCtD
Toremifene—Asthenia—Methotrexate—hematologic cancer	1.73e-05	0.000102	CcSEcCtD
Toremifene—Nausea—Prednisone—hematologic cancer	1.71e-05	0.000101	CcSEcCtD
Toremifene—Pruritus—Methotrexate—hematologic cancer	1.7e-05	0.000101	CcSEcCtD
Toremifene—Asthenia—Epirubicin—hematologic cancer	1.61e-05	9.56e-05	CcSEcCtD
Toremifene—Pruritus—Epirubicin—hematologic cancer	1.59e-05	9.42e-05	CcSEcCtD
Toremifene—Dizziness—Methotrexate—hematologic cancer	1.59e-05	9.41e-05	CcSEcCtD
Toremifene—Vomiting—Methotrexate—hematologic cancer	1.53e-05	9.05e-05	CcSEcCtD
Toremifene—Rash—Methotrexate—hematologic cancer	1.52e-05	8.98e-05	CcSEcCtD
Toremifene—Dermatitis—Methotrexate—hematologic cancer	1.51e-05	8.97e-05	CcSEcCtD
Toremifene—Headache—Methotrexate—hematologic cancer	1.51e-05	8.92e-05	CcSEcCtD
Toremifene—Asthenia—Doxorubicin—hematologic cancer	1.49e-05	8.84e-05	CcSEcCtD
Toremifene—Dizziness—Epirubicin—hematologic cancer	1.49e-05	8.81e-05	CcSEcCtD
Toremifene—Pruritus—Doxorubicin—hematologic cancer	1.47e-05	8.72e-05	CcSEcCtD
Toremifene—Vomiting—Epirubicin—hematologic cancer	1.43e-05	8.47e-05	CcSEcCtD
Toremifene—Nausea—Methotrexate—hematologic cancer	1.43e-05	8.46e-05	CcSEcCtD
Toremifene—Rash—Epirubicin—hematologic cancer	1.42e-05	8.4e-05	CcSEcCtD
Toremifene—Dermatitis—Epirubicin—hematologic cancer	1.42e-05	8.39e-05	CcSEcCtD
Toremifene—Headache—Epirubicin—hematologic cancer	1.41e-05	8.35e-05	CcSEcCtD
Toremifene—Dizziness—Doxorubicin—hematologic cancer	1.38e-05	8.15e-05	CcSEcCtD
Toremifene—Nausea—Epirubicin—hematologic cancer	1.34e-05	7.91e-05	CcSEcCtD
Toremifene—Vomiting—Doxorubicin—hematologic cancer	1.32e-05	7.84e-05	CcSEcCtD
Toremifene—Rash—Doxorubicin—hematologic cancer	1.31e-05	7.77e-05	CcSEcCtD
Toremifene—Dermatitis—Doxorubicin—hematologic cancer	1.31e-05	7.76e-05	CcSEcCtD
Toremifene—Headache—Doxorubicin—hematologic cancer	1.3e-05	7.72e-05	CcSEcCtD
Toremifene—Nausea—Doxorubicin—hematologic cancer	1.24e-05	7.32e-05	CcSEcCtD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	7.06e-06	0.000113	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ENO2—hematologic cancer	7.05e-06	0.000113	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GSTO1—hematologic cancer	7.04e-06	0.000113	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ABCC3—hematologic cancer	7.04e-06	0.000113	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—TXN—hematologic cancer	7.04e-06	0.000113	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IL3—hematologic cancer	7e-06	0.000112	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—AGRN—hematologic cancer	6.98e-06	0.000112	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PC—hematologic cancer	6.97e-06	0.000111	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—SPHK1—hematologic cancer	6.89e-06	0.00011	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PTPN1—hematologic cancer	6.88e-06	0.00011	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GSTT1—hematologic cancer	6.84e-06	0.000109	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—MAPK14—hematologic cancer	6.77e-06	0.000108	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—RASGRP1—hematologic cancer	6.77e-06	0.000108	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SYK—hematologic cancer	6.74e-06	0.000108	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HSP90AA1—hematologic cancer	6.74e-06	0.000108	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GBA—hematologic cancer	6.73e-06	0.000108	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SLC35B2—hematologic cancer	6.73e-06	0.000108	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	6.73e-06	0.000108	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—SDC1—hematologic cancer	6.68e-06	0.000107	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—UGT1A1—hematologic cancer	6.62e-06	0.000106	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—IDH2—hematologic cancer	6.61e-06	0.000106	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—HMMR—hematologic cancer	6.61e-06	0.000106	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—STAT1—hematologic cancer	6.5e-06	0.000104	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	6.49e-06	0.000104	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—SLC22A1—hematologic cancer	6.44e-06	0.000103	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CRABP1—hematologic cancer	6.44e-06	0.000103	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—NOTCH1—hematologic cancer	6.42e-06	0.000103	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.38e-06	0.000102	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	6.3e-06	0.000101	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ALOX5—hematologic cancer	6.28e-06	0.0001	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	6.28e-06	0.0001	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	6.24e-06	9.97e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ARNTL—hematologic cancer	6.22e-06	9.94e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—MTAP—hematologic cancer	6.16e-06	9.85e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—GRB2—hematologic cancer	6.08e-06	9.73e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—NUP98—hematologic cancer	6.08e-06	9.72e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PDGFA—hematologic cancer	6.07e-06	9.7e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CA9—hematologic cancer	6.05e-06	9.67e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ACP5—hematologic cancer	6.05e-06	9.67e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	6.03e-06	9.64e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—KITLG—hematologic cancer	5.98e-06	9.56e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—NCOR2—hematologic cancer	5.97e-06	9.54e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ADCY7—hematologic cancer	5.9e-06	9.44e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—NCOA3—hematologic cancer	5.9e-06	9.44e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—NUP214—hematologic cancer	5.86e-06	9.37e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—STAT5A—hematologic cancer	5.85e-06	9.35e-05	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—CREBBP—hematologic cancer	5.82e-06	9.31e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CDKN2B—hematologic cancer	5.8e-06	9.27e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ABCG2—hematologic cancer	5.74e-06	9.18e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—MTR—hematologic cancer	5.74e-06	9.18e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—IDH1—hematologic cancer	5.69e-06	9.09e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CD44—hematologic cancer	5.68e-06	9.08e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—NQO1—hematologic cancer	5.68e-06	9.08e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ENO2—hematologic cancer	5.63e-06	9e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ABCC3—hematologic cancer	5.62e-06	8.99e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—TXN—hematologic cancer	5.62e-06	8.99e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GSTO1—hematologic cancer	5.62e-06	8.99e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CD86—hematologic cancer	5.61e-06	8.96e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.56e-06	8.9e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HES1—hematologic cancer	5.53e-06	8.84e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—SPHK1—hematologic cancer	5.5e-06	8.8e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NCOR1—hematologic cancer	5.5e-06	8.79e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—FHL2—hematologic cancer	5.49e-06	8.78e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GSTT1—hematologic cancer	5.46e-06	8.73e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—FGF1—hematologic cancer	5.44e-06	8.69e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CSF2—hematologic cancer	5.44e-06	8.69e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—AGRN—hematologic cancer	5.38e-06	8.61e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CYCS—hematologic cancer	5.38e-06	8.6e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—FOXO1—hematologic cancer	5.36e-06	8.56e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PDGFRB—hematologic cancer	5.35e-06	8.55e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—HSP90AA1—hematologic cancer	5.34e-06	8.54e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—SDC1—hematologic cancer	5.34e-06	8.53e-05	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	5.3e-06	8.47e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—UGT1A1—hematologic cancer	5.29e-06	8.45e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PDGFRA—hematologic cancer	5.27e-06	8.42e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—JAK1—hematologic cancer	5.25e-06	8.39e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PRKCG—hematologic cancer	5.25e-06	8.39e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CRABP1—hematologic cancer	5.14e-06	8.22e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—SLC22A1—hematologic cancer	5.14e-06	8.22e-05	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.11e-06	8.17e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—IDH2—hematologic cancer	5.1e-06	8.16e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—HMMR—hematologic cancer	5.1e-06	8.16e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ALOX5—hematologic cancer	5.01e-06	8.01e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IL2RA—hematologic cancer	4.9e-06	7.83e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—NUP98—hematologic cancer	4.85e-06	7.76e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TERT—hematologic cancer	4.85e-06	7.75e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.81e-06	7.69e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ARNTL—hematologic cancer	4.8e-06	7.67e-05	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	4.79e-06	7.65e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GSTP1—hematologic cancer	4.74e-06	7.58e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PDGFB—hematologic cancer	4.73e-06	7.56e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ADCY7—hematologic cancer	4.71e-06	7.53e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—NCOA3—hematologic cancer	4.71e-06	7.53e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—NUP214—hematologic cancer	4.68e-06	7.48e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CA9—hematologic cancer	4.67e-06	7.46e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ACP5—hematologic cancer	4.67e-06	7.46e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.63e-06	7.4e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TSC2—hematologic cancer	4.62e-06	7.39e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—NCOR2—hematologic cancer	4.61e-06	7.36e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.59e-06	7.33e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—MTR—hematologic cancer	4.58e-06	7.33e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ABCG2—hematologic cancer	4.58e-06	7.33e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—NQO1—hematologic cancer	4.54e-06	7.26e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CD44—hematologic cancer	4.54e-06	7.26e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ENO2—hematologic cancer	4.5e-06	7.19e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ABCB1—hematologic cancer	4.49e-06	7.17e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—FGFR3—hematologic cancer	4.45e-06	7.11e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MAPK14—hematologic cancer	4.4e-06	7.04e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—IDH1—hematologic cancer	4.39e-06	7.02e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GSTT1—hematologic cancer	4.36e-06	6.97e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GSTM1—hematologic cancer	4.36e-06	6.96e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—NCOR1—hematologic cancer	4.36e-06	6.96e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTO1—hematologic cancer	4.34e-06	6.94e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ABCC3—hematologic cancer	4.34e-06	6.94e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—TXN—hematologic cancer	4.34e-06	6.94e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYCS—hematologic cancer	4.3e-06	6.87e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.29e-06	6.86e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—HSP90AA1—hematologic cancer	4.27e-06	6.82e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—FN1—hematologic cancer	4.27e-06	6.82e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—SDC1—hematologic cancer	4.26e-06	6.81e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SPHK1—hematologic cancer	4.25e-06	6.79e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—BAD—hematologic cancer	4.22e-06	6.74e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NFKBIA—hematologic cancer	4.22e-06	6.74e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NOTCH1—hematologic cancer	4.17e-06	6.67e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CD80—hematologic cancer	4.09e-06	6.54e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—KIT—hematologic cancer	4.08e-06	6.53e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PIK3CG—hematologic cancer	4.08e-06	6.53e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—UGT1A1—hematologic cancer	4.08e-06	6.52e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.07e-06	6.51e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.02e-06	6.42e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PTPN11—hematologic cancer	4.01e-06	6.41e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.97e-06	6.34e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.97e-06	6.34e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CREB1—hematologic cancer	3.89e-06	6.21e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ALOX5—hematologic cancer	3.87e-06	6.18e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—MTHFR—hematologic cancer	3.85e-06	6.15e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.84e-06	6.14e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—BRAF—hematologic cancer	3.84e-06	6.13e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CCL2—hematologic cancer	3.8e-06	6.08e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IL6R—hematologic cancer	3.79e-06	6.06e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GSTP1—hematologic cancer	3.79e-06	6.05e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CREBBP—hematologic cancer	3.79e-06	6.05e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—NUP98—hematologic cancer	3.75e-06	5.99e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.64e-06	5.81e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.64e-06	5.81e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—NQO1—hematologic cancer	3.62e-06	5.79e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CD44—hematologic cancer	3.62e-06	5.79e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MAP2K1—hematologic cancer	3.61e-06	5.77e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—NUP214—hematologic cancer	3.61e-06	5.77e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PIK3CD—hematologic cancer	3.59e-06	5.74e-05	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—MAPK3—hematologic cancer	3.55e-06	5.68e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.55e-06	5.67e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.54e-06	5.66e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—MTR—hematologic cancer	3.54e-06	5.66e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GSTM1—hematologic cancer	3.48e-06	5.56e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—NCOR1—hematologic cancer	3.48e-06	5.56e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ENO2—hematologic cancer	3.47e-06	5.55e-05	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—MYC—hematologic cancer	3.46e-06	5.52e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—FGF2—hematologic cancer	3.44e-06	5.49e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYCS—hematologic cancer	3.43e-06	5.48e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	3.41e-06	5.45e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.39e-06	5.42e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PIK3R1—hematologic cancer	3.39e-06	5.42e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.37e-06	5.38e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—JAK2—hematologic cancer	3.29e-06	5.26e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SDC1—hematologic cancer	3.29e-06	5.26e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PIK3CG—hematologic cancer	3.23e-06	5.17e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MDM2—hematologic cancer	3.22e-06	5.14e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MTOR—hematologic cancer	3.13e-06	5e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PIK3CB—hematologic cancer	3.13e-06	5e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—MTHFR—hematologic cancer	3.07e-06	4.91e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.07e-06	4.9e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GSTP1—hematologic cancer	3.02e-06	4.83e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CREBBP—hematologic cancer	3e-06	4.79e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CDKN1B—hematologic cancer	2.94e-06	4.69e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.92e-06	4.67e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CASP3—hematologic cancer	2.88e-06	4.6e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IL2—hematologic cancer	2.87e-06	4.59e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ABCB1—hematologic cancer	2.86e-06	4.57e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PIK3CD—hematologic cancer	2.84e-06	4.54e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ALB—hematologic cancer	2.81e-06	4.49e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CCND1—hematologic cancer	2.8e-06	4.48e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—NQO1—hematologic cancer	2.8e-06	4.47e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CD44—hematologic cancer	2.8e-06	4.47e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—JUN—hematologic cancer	2.79e-06	4.47e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—NCOR1—hematologic cancer	2.78e-06	4.44e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GSTM1—hematologic cancer	2.78e-06	4.44e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CDKN1A—hematologic cancer	2.71e-06	4.33e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PTEN—hematologic cancer	2.7e-06	4.32e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PIK3R1—hematologic cancer	2.68e-06	4.29e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYCS—hematologic cancer	2.65e-06	4.23e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MAPK8—hematologic cancer	2.64e-06	4.23e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.63e-06	4.2e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PIK3CG—hematologic cancer	2.58e-06	4.13e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—EP300—hematologic cancer	2.58e-06	4.12e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SRC—hematologic cancer	2.51e-06	4.01e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PIK3CB—hematologic cancer	2.48e-06	3.96e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—MTHFR—hematologic cancer	2.45e-06	3.92e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—VEGFA—hematologic cancer	2.44e-06	3.9e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—STAT3—hematologic cancer	2.42e-06	3.86e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NRAS—hematologic cancer	2.41e-06	3.85e-05	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—AKT1—hematologic cancer	2.4e-06	3.83e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CREBBP—hematologic cancer	2.4e-06	3.83e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.33e-06	3.73e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MAPK3—hematologic cancer	2.31e-06	3.69e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PIK3CD—hematologic cancer	2.27e-06	3.63e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MYC—hematologic cancer	2.25e-06	3.59e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ALB—hematologic cancer	2.24e-06	3.58e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TGFB1—hematologic cancer	2.24e-06	3.58e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.21e-06	3.53e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.16e-06	3.46e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PIK3R1—hematologic cancer	2.14e-06	3.43e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.14e-06	3.43e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.14e-06	3.43e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PTEN—hematologic cancer	2.14e-06	3.42e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—KRAS—hematologic cancer	2.08e-06	3.32e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PIK3CG—hematologic cancer	2.06e-06	3.3e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—EP300—hematologic cancer	2.04e-06	3.26e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.98e-06	3.16e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.91e-06	3.06e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PIK3CA—hematologic cancer	1.91e-06	3.05e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.89e-06	3.03e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TP53—hematologic cancer	1.84e-06	2.95e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.81e-06	2.9e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ALB—hematologic cancer	1.79e-06	2.86e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HRAS—hematologic cancer	1.76e-06	2.82e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.71e-06	2.74e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PTEN—hematologic cancer	1.71e-06	2.73e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IL6—hematologic cancer	1.69e-06	2.7e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—EP300—hematologic cancer	1.63e-06	2.61e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.59e-06	2.54e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.58e-06	2.53e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—AKT1—hematologic cancer	1.56e-06	2.49e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PIK3CA—hematologic cancer	1.51e-06	2.41e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.48e-06	2.36e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.4e-06	2.24e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ALB—hematologic cancer	1.38e-06	2.21e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PTEN—hematologic cancer	1.37e-06	2.18e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.32e-06	2.11e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—EP300—hematologic cancer	1.3e-06	2.08e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—AKT1—hematologic cancer	1.23e-06	1.97e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.22e-06	1.95e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PIK3CA—hematologic cancer	1.21e-06	1.93e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PTEN—hematologic cancer	1.05e-06	1.68e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—EP300—hematologic cancer	1.01e-06	1.61e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—AKT1—hematologic cancer	9.86e-07	1.58e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PIK3CA—hematologic cancer	9.63e-07	1.54e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—AKT1—hematologic cancer	7.87e-07	1.26e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PIK3CA—hematologic cancer	7.43e-07	1.19e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—AKT1—hematologic cancer	6.07e-07	9.71e-06	CbGpPWpGaD
